U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
182221182221Community Based Trial for AMEVIVE®CompletedNo Results AvailableModerate to Severe Chronic Plaque PsoriasisDrug: Alefacepthttps://ClinicalTrials.gov/show/NCT00168753
182222182222Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)CompletedNo Results AvailableLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaDrug: rituximabhttps://ClinicalTrials.gov/show/NCT00168740
182223182223Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s LymphomaCompletedNo Results AvailableLymphoma, Non-Hodgkin|Lymphoma, Low-GradeDrug: ibritumomab tiuxetan (Zevalin®)https://ClinicalTrials.gov/show/NCT00168727
182224182224Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)CompletedNo Results AvailablePrenatal Exposure Delayed Effects|Multiple Sclerosis|PregnancyDrug: BG9418 (interferon beta-1a)https://ClinicalTrials.gov/show/NCT00168714
182225182225Efficacy and Safety of BG00012 in MSCompletedNo Results AvailableMultiple SclerosisDrug: BG00012https://ClinicalTrials.gov/show/NCT00168701
182226182226Prenatal Multi-micronutrient Supplementation and Pregnancy OutcomeCompletedNo Results AvailablePregnancy|Birth WeightDietary Supplement: multi micronutrient supplement|Dietary Supplement: MN1|Dietary Supplement: MN2https://ClinicalTrials.gov/show/NCT00168688
182227182227Non-Specific Effects of Standard Titre Measles VaccinationCompletedNo Results AvailableMeaslesBiological: Measles and inactivated polio vaccinehttps://ClinicalTrials.gov/show/NCT00168662
182228182228Vitamin A and Response to EndotoxinActive, not recruitingNo Results AvailableTNF-alfa|Endotoxin LevelsDrug: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00168649
182229182229Different Doses of Vitamin A Supplementation and Male and Female Morbidity and MortalityCompletedNo Results AvailableMortality|MorbidityDrug: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00168636
182230182230Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and MorbidityActive, not recruitingNo Results AvailableMortality|MorbidityDrug: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00168623
182231182231Vitamin A Supplementation With Bacille Calmette Guerin (BCG) VaccineActive, not recruitingNo Results AvailableInfant Mortality|MorbidityDrug: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00168610
182232182232Vitamin A With BCG VaccineCompletedNo Results AvailableMortality|MorbidityDrug: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00168597
182233182233Different Doses of Vitamin A and Childhood Morbidity and MortalityCompletedNo Results AvailableMortality|MorbidityDrug: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00168584
182234182234Long-term Follow-up of Measles AntibodiesCompletedNo Results AvailableMeaslesBiological: Measles vaccinehttps://ClinicalTrials.gov/show/NCT00168571
182235182235Early Two-dose Measles Vaccination TrialCompletedNo Results AvailableMeaslesBiological: Measles vaccinehttps://ClinicalTrials.gov/show/NCT00168558
182236182236Immunology of Non-specific Effects of VaccineCompletedNo Results AvailableMeasles|Diphtheria|Tetanus|PertussisBiological: Measles vaccinehttps://ClinicalTrials.gov/show/NCT00168545
182237182237Prophylactic Antibiotics in MeaslesCompletedNo Results AvailablePost-Measles Pneumonia|MeaslesDrug: Sulfamethoxazole-Trimethoprimhttps://ClinicalTrials.gov/show/NCT00168532
182238182238Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: nitroprusside, pentalong, imdur, AICAR, isoptinhttps://ClinicalTrials.gov/show/NCT00168519
182239182239Panic Disorder and Cardiac RiskRecruitingNo Results AvailablePanic DisorderDrug: SSRI|Drug: CBT|Drug: CBT/SSRIhttps://ClinicalTrials.gov/show/NCT00168506
182240182240The Neurobiology of Depressive IllnessRecruitingNo Results AvailableMajor DepressionDrug: antidepressants primarily selective serotonin reuptake inhibitorshttps://ClinicalTrials.gov/show/NCT00168493
182241182241A Study Using Botulinum Toxin Type A in Patients With Axillary HyperhidrosisCompletedNo Results AvailableHyperhidrosisBiological: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT00168480
182242182242The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial DiseaseCompletedNo Results AvailablePeripheral Arterial DiseaseDrug: Ramiprilhttps://ClinicalTrials.gov/show/NCT00168467
182243182243A Research Study for Patients With Overactive BladderCompletedHas ResultsOveractive Bladder|Urinary IncontinenceBiological: botulinum toxin Type A|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00168454
182244182244A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic NeuralgiaCompletedNo Results AvailablePostherpetic NeuralgiaDrug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT00168441
182245182245A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent HeadachesCompletedHas ResultsMigraine DisordersBiological: Botulinum Toxin Type A|Other: placebo (saline)https://ClinicalTrials.gov/show/NCT00168428
182246182246A Study Using Botulinum Toxin Type A in Adolescents With Axillary HyperhidrosisCompletedNo Results AvailableHyperhidrosisBiological: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT00168415
182247182247A Study Using Botulinum Toxin Type A in Patients With Axillary HyperhidrosisCompletedNo Results AvailableHyperhidrosisDrug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT00168402
182248182248A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedHas ResultsDiabetic Macular EdemaDrug: Dexamethasone|Other: Shamhttps://ClinicalTrials.gov/show/NCT00168389
182249182249A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDevice: Transcranial Magnetic Stimulationhttps://ClinicalTrials.gov/show/NCT00168376
182250182250Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableGlaucoma|Ocular HypertensionDrug: brimonidinehttps://ClinicalTrials.gov/show/NCT00168363

* Görseller ve İçerik tekif hakkına sahip olabilir